ASX Home Page Listed @ ASX - October 2005
Useful Links
  • ASX Online
  • Information for Companies
  • Today's company announcements
  • Corporate Governance
  • Current S&P/ASX Indices
  • ASX Listing Rules
  • ASX-Listed Emblem
  • Listing on ASX
    • Learn more about the ASX-Listed Emblem
    In this Issue
  • Maximising your investor communication potential
  • Float of the Month
  • Results of ASX's SME Survey June-July 2005
  • Upcoming events
    • Welcome to the monthly Listed @ ASX newsletter. This newsletter is intended for Managing Directors, Company Secretaries, other senior managers and corporate advisers. To subscribe or unsubscribe, please see below.
    Maximising your investor communication potential
    Following on from last month's article on being prepared for your Annual General Meeting (AGM), Christine Harris of boardroomradio.com provides insight into how to maximise participation at your AGM and ways you can enhance your existing investor relations program.
    Float of the Month
    In September, 21 entities were added to the official list of the Australian stock exchange providing ASX with a total of 1813 listed entities at the end of the month.
    Results of ASX's SME Survey June-July 2005
    The results of the survey shows that the top priorities of listed SMEs are to:
    1. Increase capital raising limits
    2. Find more effective and efficient ways to communicate with investors
    3. Stimulate more research coverage on their stock
    Upcoming events
  • Chartered Secretaries Australia - 21-23 November

    Chartered Secretaries Australia's 22nd National Conference will be held from 21 - 23 November 2005, at the Hilton Sydney. The conference will provide relevant and practical information for publicly listed companies including latest reforms in regulation, risk management, compliance, insurance, OH&S, corporate social responsibility, IT governance. Tony D'Aloisio managing director and chief executive officer of Australian Stock Exchange will speak in 'The Kaleidoscope of Governance' session on day one.
  • AusBiotech 2005 National Conference - 20-23 November

    The AusBiotech National Conference will be held from November 20-23 at the Perth Convention Exhibition Centre, Western Australia. The conference program features three components:
    1. Conference program extending over three days with sessions that encompass key sectors of the biotechnology industry
    2. BioIndustry Exhibition
    3. Business Partnering and invest Forum that will give companies the opportunity to present their technologies and services to investors and potential partners
  • Company orientation sessions

    ASX runs company orientation sessions for newly listed companies or new staff at existing listed companies. The seminar covers topics such as continuous disclosure and ongoing compliance issues, how announcements are released to the market, price queries and trading halts. Chief Financial Officers, Company Secretaries, Legal and Investor Relations staff and Company Directors are encouraged to attend. Registrations are essential.

    Location: Perth
    Time: 12.00 to 2.00pm, Tuesday 5 December
    Venue: ASX, Exchange Plaza, 2 The Esplanade, Perth Location: Melbourne
    Time: 2.00 to 5.00pm, Tuesday 15 November
    Venue: ASX, 530 Collins Street, Melbourne
    • ASX Home Page
    Comments or feedback, please contact the editor: James Watts
    SUBSCRIBE:
    To subscribe to this newsletter please visit the Listings page and complete the details in the box on the left hand side of the page.
    UNSUBSCRIBE:
    To unsubscribe please visit the unsubscribe page.
    NOTICE
    © 2005 Australian Stock Exchange Limited, 20 Bridge Street, Sydney NSW 2000, Australia. 
    131 279. All Rights Reserved.

    Australian Stock Exchange Limited believes that all information contained herein is accurate and reliable. However no warranty of accuracy or reliability as to such information is given and no responsibility for loss arising in any way from or in connection with errors or omissions in any information (including responsibility to any person by reason of negligence) is accepted by Australian Stock Exchange Limited, its subsidiaries or their employees. The information contained in this email should in no way be construed to constitute financial advice or a recommendation by Australian Stock Exchange Limited with respect to the purchase or sale of any securities. Independent professional advice should be sought before making any investment decision.